MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression
10.1038/s41598-019-49155-4
Saved in:
Main Authors: | Nama, S., Muhuri, M., Di Pascale, F., Quah, S., Aswad, L., Fullwood, M., Sampath, P. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
Nature Publishing Group
2022
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/213243 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
MicroRNA-138 is a prognostic biomarker for triple-negative breast cancer and promotes tumorigenesis via TUSC2 repression
by: Nama, Srikanth, et al.
Published: (2020) -
C/EBPβ mediates RNA polymerase III-driven transcription of oncomiR-138 in malignant gliomas
by: Di Pascale, F., et al.
Published: (2021) -
TRANSCRIPTIONAL REGULATION OF ONCOMIR-138 IN MALIGNANT GLIOMAS
by: DI PASCALE FEDERICA
Published: (2017) -
Harnessing the power of microRNAs as prognostic biomarkers in acute heart failure
by: Wong, Lee Lee, et al.
Published: (2022) -
Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
by: Jin, Y., et al.
Published: (2021)